Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05068349
PHASE4

For Patients With Ischemic Stroke, Clinically Study the Effectiveness and Safety of Butylphthalide.

Sponsor: Qianfoshan Hospital

View on ClinicalTrials.gov

Summary

This is a prospective, open, single-arm, the real world of clinical trials. The researchers plan to recruit 300 eligible patients. The main purpose of this study is to evaluate the effectiveness and safety of butylphthalide in the treatment of ischemic stroke, and to establish a population pharmacokinetic model of butylphthalide in elderly patients to explore its blood drug concentration. Correlation with its efficacy and adverse reactions.

Official title: A Real-world Study on the Effectiveness and Safety of Butylphthalide in the Treatment of Ischemic Stroke.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

300

Start Date

2022-05-07

Completion Date

2025-12

Last Updated

2024-04-09

Healthy Volunteers

No

Interventions

DRUG

Butylphthalide

Butylphthalide sodium chloride injection 25mg, 2 times a day, 7-14 days, followed by 0.2g butylphthalide soft capsules, 3 times a day, 76-83 days, a total of 90 days.

Locations (1)

Shandong Provincial Qianfoshan Hospital

Jinan, Shandong Provincial, China